Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Territory by territory, the US market is set to endure the worst growth rate of 2009, with IMS predicting -1 to -2% growth there. Europe fares a little better with 2Ð3% growth, but everywhere will be left standing by the growth rate predicted for the seven 'pharmerging markets' , which are collectively predicted to grow by a whopping 13-14%.


Today in Marketing/Media/ROI...keeping you current

Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/09/09

EMEA recommends authorization of swine flu vaccines
Pharmaceutical Technology, 10/14/09

Nabi Biopharmaceuticals Completes Sale of PentaStaph to GlaxoSmithKline PLC
Nabi Biopharmaceuticals, 11/05/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address